Reporting by Karolina Tagaris, Angeliki Koutantou; editing by James MackenzieOur Standards: The Thomson Reuters Trust Principles. Gruber anticipates data from those trials will likely be available "late at the end of the year or beginning of 2022." However, he said Pfizer has data that indicates a fully-vaccinated person's current dosage could be highly effective "at least up to 6 months," and possibly more. "We obviously are very attentive to being deliberate and careful, as we move down in age," he said. He said it presented "an opportunity to get back to normal life."
James Mackenzie was not directly responsible for pfizer's actions.
( z0 responsible :ARG0 ( z1 person :name ( z2 name :op "James" :op "Mackenzie" ) ) :ARG1 ( z3 act :ARG0 ( z4 company :name ( z5 name :op "Pfizer" ) ) ) :ARG1-of ( z6 direct ) :polarity - )
(z0 / responsible-01
    :ARG0 (z1 / person
              :name (z2 / name
                        :op1 "James"
                        :op2 "Mackenzie"))
    :ARG1 (z3 / act-02
              :ARG0 (z4 / company
                        :name (z5 / name
                                  :op1 "Pfizer")))
    :ARG1-of (z6 / direct-02)
    :polarity -)
James Mackenzie was not directly responsible for pfizer 's actions .
z2 :op1 1
z1 :name z2
z2 :op2 2
z0 :ARG1-of z6
z0 :polarity 0
z0 :ARG0 z1
z4 :name z5
z5 :op1 3
z3 :ARG0 z4
z0 :ARG1 z3